nebulized inhalation of pegylated interferon alpha-2b injection (Xiamen Amoytop Biotech)
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug Namenebulized inhalation of pegylated interferon alpha-2b injection (Xiamen Amoytop Biotech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXiamen Amoytop Biotech Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesXiamen Amoytop Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A